Hôpital Pierre Wertheimer

Running trials

• Not yet recruiting

  Clinical, Electrophysiological and Genetic Characteristics of Hereditary and Inflammatory Polyneuropathies in France

  NCT07851844· Assistance Publique - Hôpitaux de Paris· Source

• Not yet recruiting

  Neurogenetics and Multi-omics of Neuroinflammatory Diseases in Multiplex Families to Improve Patients Health

  NCT07902479· Institut National de la Santé Et de la Recherche Médicale, France· Source

• Recruiting

  ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY

  NCT07545512· University Hospital, Clermont-Ferrand· Source

• Not yet recruiting

  Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicenter Randomized Controlled Trial (IVT-ALL-IN)

  NCT07603440· Phase 3· Assistance Publique - Hôpitaux de Paris· Source

• Recruiting

  Caracterization of the Combined Alterations in Respiration and aROUSal in Patients With Drug-resistant EpiLepsy

  NCT06545214· Hospices Civils de Lyon· Source

• Recruiting

  Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)

  NCT06347315· Société des Produits Nestlé (SPN)· Source

• Recruiting

  Evaluation of Tibial Nerve Selective Neurotomy Compared to Botulinum Toxin Injections for Spastic Foot Treatment in Post-stroke Patients According to a Goal-centered Approach

  NCT05874154· Hospices Civils de Lyon· Source

• Active, not recruiting

  Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial

  NCT05999604· Phase 3· Fondation Ophtalmologique Adolphe de Rothschild· Source

• Recruiting

  Hizentra® in Inflammatory Neuropathies - pHeNIx Study

  NCT04672733· CSL Behring· Source

• Recruiting

  CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in Stroke - HIBISCUS-STROKE II

  NCT05263804· Hospices Civils de Lyon· Source

• Active, not recruiting

  French eCLIPs™ Efficacy and Safety Investigation

  NCT05330897· Evasc Medical Systems Corp.· Source

• Recruiting

  Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura

  NCT04063540· Phase 2· Centre Hospitalier Universitaire de Nice· Source

• Recruiting

  Lyon Registry of Stroke Treated by Thrombolysis or Thrombectomy

  NCT04620642· Hospices Civils de Lyon· Source

• Recruiting

  Multimodal Monitoring Study in Neuro Critical Care

  NCT06900101· Hospices Civils de Lyon· Source

• Recruiting

  Biological Bank for Atrial Fibrillation and Stroke

  NCT03611816· Hospices Civils de Lyon· Source

• Recruiting

  Neurovascular Product Surveillance Registry

  NCT02988128· Medtronic Neurovascular Clinical Affairs· Source

• Active, not recruiting

  A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

  NCT02130362· AbbVie· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke6 recruiting
• CIDP (chronic inflammatory demyelinating polyneuropathy)2 recruiting
• Atrial fibrillation1 recruiting
• Brain aneurysm1 recruiting
• Charcot-Marie-Tooth disease1 recruiting
• Coronary artery disease1 recruiting
• Epilepsy1 recruiting
• High blood pressure1 recruiting
• Migraine1 recruiting
• Mild cognitive impairment1 recruiting
• Multiple sclerosis1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting

Closed trials

• Completed

  Evaluation of the Prognostic Impact of a Neuro-vascular Examination Associated With Cerebral MRI in the Acute Phase of Infectious Endocarditis

  NCT05378126· Hospices Civils de Lyon· Source

• Completed

  Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM

  NCT04471844· NovoCure Ltd.· Source

• Completed

  In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO

  NCT04629274· Imcyse SA· Source

• Completed

  MiDura-Study (Neuro-Patch in Duraplasty)

  NCT04189172· Aesculap AG· Source

• Completed

  Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis

  NCT03293069· Phase 2/3· University Hospital, Lille· Source

• Completed

  Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)

  NCT02864004· Phase 3· Rennes University Hospital· Source

• Completed

  Predictive Factors and Subthalamic Stimulation in Parkinson's Disease

  NCT02360683· University Hospital, Lille· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Neuromyelitis optica (NMOSD)10 works · 2 trials
• Optic neuritis4 works · 0 trials